Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-21
2005-06-21
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S457000, C549S400000
Reexamination Certificate
active
06908942
ABSTRACT:
The present invention provides (i) 6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran derivatives; (ii) a process for synthesizing benzopyran derivatives with high efficiency by parallel synthesis on a solid-phase as one of combinatorial chemical synthesis technologies; and (iii) a use of the benzopyran derivatives for preventing and treating diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products.
REFERENCES:
patent: 6555574 (2003-04-01), Tanikawa et al.
I. Sziráki et al., “Manganese: A Transition Metal Protects Nigrostriatal Neurons From Oxidative Stress In The Iron-Induced Animal Model Of Parkinsonism,” Neurosci. 85, 1998, pp. 1101-1111.
Y. Goodman, et al., “K+ channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity,” Brain Research 706, 1996, pp. 328-332.
Gong Young-Dae
Hwang Jong Yeon
Seo Jin-Soo
Yoo Sung-eun
Convington Raymond
Desai Rita
Korea Research Institute of Chemical Technology
LandOfFree
6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-amino-2,2-dimethyl-3,4,6-trisubstituted benzopyran... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3504434